Skip to content

Omeros OMER Interest Expense

Discontinued — last reported Q2 '23

Interest Expense at other companies

Arcus Biosciences logo
Arcus BiosciencesRCUS
$3M+200%
Allogene Therapeutics logo
Allogene TherapeuticsALLO
$300K+100%
Vera Therapeutics logo
Vera TherapeuticsVERA
$1.82M+1.7%
Opko Health logo
Opko HealthOPK
$10.94M-29.3%

Other financials

Income statement

See full
Revenue$9.9M
Gross profit$29.7M
Operating income-$40.9M-9.2%
Net income$56.1M+268%
EPS (diluted)-$0.59-20.4%

Balance sheet

See full
Cash & equivalents$1.9M-55.3%
Total debt$13.5M-30.3%
Total equity-$63.3M+70.3%
Total assets$286.2M+21.7%

Cash flow

See full
Operating cash flow-$14.5M+59.5%
CapEx--100%
Free cash flow-$14.5M+59.6%

Valuation

See full
Market cap$775.86M+313%
P/S8.6×

Profitability

See full
Gross margin98.9%
Operating margin-181.8%
Net margin-136.6%
FCF margin-121.6%

Returns & leverage

See full
Return on equity86.6%
Debt / equity0.3×-1.1×
Current ratio+1.9×

Where this comes from

Reported directly by Omeros in its filing.

Tagged under the XBRL concept us-gaap:InterestExpense.

The official record: Omeros’s 10-Q, filed August 9, 2023, on SEC EDGAR. View the filing →

Ask your AI about Omeros's interest expense.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Omeros's interest expense?
Omeros (OMER) reported interest expense of $7.93M in Q2 2023.
How has Omeros's interest expense changed year-over-year?
Omeros's interest expense increased by 61.0% year-over-year, from $4.93M to $7.93M.
What does interest expense mean?
Cost of borrowing — interest paid or accrued on bonds, bank loans, credit facilities, finance leases, and other debt obligations.